Press Release:
Without directly invading the brain or nerves, the virus responsible for COVID-19 causes potentially damaging neurological injuries in about one in seven infected, a new study shows. These injuries range from temporary confusion due to low body-oxygen levels, to stroke and seizures in the most serious cases, say the study authors.
Led by researchers at NYU Grossman School of Medicine, the study showed no cases of brain or nerve inflammation (meningitis or encephalitis), indicating no immediate invasion of these organs by the pandemic virus, SARS-CoV-2.
While this should reassure patients, the neurological complications of COVID-19 should be taken seriously because they dramatically raise a patient’s risk of dying while still in hospital (by 38 percent), researchers say. Such adverse effects also raise a coronavirus patient’s likelihood (by 28 percent) of needing long-term or rehabilitation therapy immediately after their stay in hospital.
“The results of our study showed no signs that the coronavirus directly attacks the nervous system,” says study lead investigator Jennifer Frontera, MD. “The neurological complications seen in COVID-19 are predominately the secondary effects of being severely ill and suffering from low oxygen levels in the body for prolonged periods of time,” says Frontera, a professor in the Department of Neurology at NYU Langone Health.
Published in the journal Neurology online Oct. 5, the study closely monitored the progress of 606 COVID-19 adult patients diagnosed with brain or other nerve-related medical conditions at any of four NYU Langone hospitals in New York City and Long Island between March 10 and May 20, when coronavirus infections were at their peak in the region.
Frontera says that ahead of the pandemic, dozens of NYU Langone neurologists and trainees had deployed across its medical centers to assist with the expectant surge of COVID-19 patients.
Early reports from Asia and Europe, where infections had spiked before rising in the United States, she says, had also “raised the alarm” about possible brain damage from coronavirus infection. Because of this, the research team was ready to look for any signs of neurological dysfunction among the thousands of patients being admitted to hospital in the spring. Among all the hospitals, 4,491 patients tested positive for COVID-19 during that time.
Among the study’s other key results was that common neurological problems, such as confusion caused by chemical electrolyte imbalances, severe infection or kidney failure, usually arose within 48 hours of developing general COVID-19 symptoms, including fever, difficulty breathing, and cough.
Half of those neurologically affected were over the age of 71, which researchers say is significantly older than the other 3,885 patients with COVID-19 (at a media age of 63) who did not experience brain dysfunction. Most were men (66 percent) and white (63 percent). Frontera notes that the study results do suggest that Blacks are not at greater risk of neurological complications than other COVID-19 patients, which is “welcome news,” given that Blacks are widely known to be at greater risk of death from coronavirus infection. However, she says this potentially important observation requires further investigation.
While the coronavirus is known to attack other organs, including blood vessels and the heart, researchers say its main target is the lungs, where it makes breathing difficult, starving the body of oxygen it needs to stay alive. Low levels of oxygen in the body and brain was another common neurological problem, study results showed, that could lead to confusion, coma, or permanent brain damage.
“Our study results suggest that physicians need to be more aggressive in stabilizing body oxygen levels in patients with COVID-19 as a potentially key therapy for stopping, preventing and/or possibly reversing neurological problems,” says study senior investigator Steven Galetta, MD.
###
Galetta, the Philip K. Moskowitz, MD Professor and chair of the Department of Neurology at NYU Langone, says various blood-oxygen-raising therapies that could possibly work against neurological problems in patients with COVID-19 include early intubation or use of heart-lung machines, called ECMO, which mechanically “clean” the blood and “deliver” oxygen into it.
Funding support for the study was provided by National Institutes of Health grant P30 AG066512 and NYU Langone.
Advertisement:
- FDA Authorized 15-Minute Flu A&B, COVID Test Kit: Over-the-counter flu and COVID test for home use with rapid results in just 15 minutes.
- Made for Ages 2 and Above; Parents Can Stop Guessing: Quickly identify whether you or your kids are dealing with coronavirus or influenza A & B. Adult-collection is required for those aged 2-13 years, and self-collection by individuals aged 14 years and older.
- Same Ease-of-Use; Get 3 Results in 1 Test: Utilizing the familiar 4 user-friendly steps of at-home COVID tests, you can now get all 3 results for COVID-19 and Flu A & B at once with 5 drops of sample.
- Fast and Convenient COVID and Flu Tests for Home: Use this COVID and influenza rapid test kit in the comfort of your home. Bypass the need for a doctor's visit and protect your loved ones from potential exposure to contagious illnesses at school, work, or public gatherings.
- Compact Design for On-the-Go Testing: Stay safe wherever you go with our COVID-19, Flu A & B 3-in-1 self-test. Its compact design ensures easy storage and convenient portability for your travel bag.
- FDA Authorized 15-Minute Self-Test: The test is a 15-minute self-test to detect whether or not an individual has COVID-19. The test can be completed in the comfort of your own home without the need to ship your sample to a lab.
- Easy to Use with Zero Discomfort: Test can be done by inserting 1/2 to 3/4 inch of a simple non-invasive nasal swab. Step-by-step instructional videos are available in our app (Installation of app is optional).
- For Ages 2 and Above : The self-administered test is recommended for individuals aged 15 years and older. Adult-collection is required for testing children 2-14 years old.
- Manage Group Testing Via Mobile App: The iHealth Test app allows the administrator of a small group to monitor and track the group members’ test results as needed at school, work or an event.
- Independently-sealed packaging ensures safe and hygienic testing.The swabs and test cards of iHealth COVID-19 Antigen Rapid Test are sealed and independently packaged to ensure the safety and hygiene of the product.
- Expiration Date Extension: On Jan 11, 2023, the FDA granted another three-month shelf-life extension for the iHealth COVID-19 Antigen Rapid Test, which extended the shelf-life of all iHealth tests from 6 months to 15 months. Please refer to the FDA website for the detailed list of extended expiration dates by lot numbers: https://www.fda.gov/media/164551/download
- FDA Authorized 15-Minute Self-Test: The test is a 15-minute self-test to detect whether or not an individual has COVID-19. The test can be completed in the comfort of your own home without the need to ship your sample to a lab.
- Easy to Use with Zero Discomfort: The test can be done by inserting 1/2 to 3/4 inch of a simple non-invasive nasal swab. Step-by-step instructional videos are available in our app (Installation of the app is optional).
- For Ages 2 and Above: The self-administered test is recommended for individuals aged 15 years and older. Adult-collection is required for testing children 2-14 years old.
- Manage Group Testing Via Mobile App: The iHealth Test app allows the administrator of a small group to monitor and track the group members’ test results as needed at school, work, or an event.
- FDA Authorized 15-Minute Flu A&B, COVID Test Kit: Over-the-counter flu and COVID test for home use with rapid results in just 15 minutes.
- Made for Ages 2 and Above; Parents Can Stop Guessing: Quickly identify whether you or your kids are dealing with coronavirus or influenza A & B. Adult-collection is required for those aged 2-13 years, and self-collection by individuals aged 14 years and older.
- Same Ease-of-Use; Get 3 Results in 1 Test: Utilizing the familiar 4 user-friendly steps of at-home COVID tests, you can now get all 3 results for COVID-19 and Flu A & B at once with 5 drops of sample.
- Fast and Convenient COVID and Flu Tests for Home: Use this COVID and influenza rapid test kit in the comfort of your home. Bypass the need for a doctor's visit and protect your loved ones from potential exposure to contagious illnesses at school, work, or public gatherings.
- Compact Design for On-the-Go Testing: Stay safe wherever you go with our COVID-19, Flu A & B 3-in-1 self-test. Its compact design ensures easy storage and convenient portability for your travel bag.
- TRUSTED TECHNOLOGY: BinaxNOW Self Test uses the same technolgy used by doctors to test for COVID-19. Detects multiple COVID-19 variants, including Delta and Omicron*
- FAST RESULTS: FDA Authorized 15-Minute Self Test: Convenient COVID-19 at-home test provides fast, reliable results in 15 minutes, results anytime, anywhere; no need for a prescription or send to a lab.
- RELIABLE and EASY-TO-USE: Requires just a shallow nasal swab that you can do yourself; includes easy-to-follow instructions.
- FOR AGES 2 and ABOVE: COVID-19 test suitable for kids, when administered by an adult, and for all people 15 and older to self-administer.
- DETECTS ACTIVE COVID-19 INFECTION: Includes 4 rapid tests that are indicated for serial testing. Serial (or repeat) testing should be performed in individuals with negative results at least twice over three days (with at least 48 hours between tests) for symptomatic individuals and three times over five days (with at least 48 hours between tests) for asymptomatic individuals.
- FDA EUA AUTHORIZED & HSA / FSA ELIGIBLE – This at-home COVID-19 rapid antigen test is FDA Emergency Use Authorized to detect COVID-19 and its latest variants. Eligible for HSA/FSA reimbursement, making it a convenient and cost-effective testing solution.
- TRUSTED ACCURACY & RELIABILITY – With over 45 million INDICAID tests sold across 30+ countries, the INDICAID COVID test is trusted worldwide for its precision and accuracy.
- CONVENIENT & EASY TO USE – Designed for on-the-go testing with a compact package perfect for travel, school, work, and home. Requires only a shallow nasal swab and can be completed in four simple steps.
- FAMILY FRIENDLY FOR AGES 2+ – Self-administered for individuals 15+, while children aged 2-14 require adult assistance.
- EXTENDED SHELF LIFE – On January 11, 2023, the FDA granted a three-month shelf-life extension for the INDICAID COVID-19 Antigen Rapid Test, increasing its shelf life from 6 months to 15 months for longer usability.
- Self-collection for ages 14+: Ages 14+ can swab independently. Ages 2-13 need adult help for safe, accurate testing quick, easy, and reliable results.
- Fast Results in 15 Minutes: Quickly and accurately detect COVID-19 with results in just 15 minutes, helping you make informed decisions for your health.
- Comfortable & Non-Invasive Nasal Swabs: Gentle, short nasal swabs ensure a comfortable and easy at-home testing process for all users.
- HSA/FSA Eligible: Get reimbursed for this affordable at-home test—easy, accessible, and budget-friendly. Take control of your health with confidence today!
- Convenient at-home testing: The test allows for quick and reliable results for individuals aged 2+, with proper procedures for self-testing and assisted testing.
- Bryan Ardis (Author)
- English (Publication Language)
- 312 Pages - 10/01/2024 (Publication Date) - Harvest Creek Publishing (Publisher)
- Non-invasive nasal swab, easy to use and convenient for Covid-19 test kit for home use or traveling.
- Rapid and reliable result in 15 minutes.
- Nasal test kit designed for user with symptom or without symptom. Detects multiple COVID-19 strains, including the Delta and Omicron variants.
- This test is authorized for non-prescription home use with self-collected nasal swab specimens from individuals aged 14 years and older or with adult-collected samples from individuals aged 2 years or older.
- The pack comes with 2 or 4 (Best Value) tests kit. HSA/FSA Eligible.
- Expiration Date Extension: On March 15, 2023, the FDA granted the Flowflex COVID-19 Antigen Home Test another 3-month shelf-life extension, which extended the shelf-life of the product from 12 months to 24 months. Refer to the FDA website for the extended expiration dates.
- FDA EUA Authorized COVID-19 Home Test – This test is authorized for home use without the need for a prescription or sending to a lab.
- Detects Active COVID-19 Infection - This test detects multiple COVID-19 variants including the Omicron and Delta variants.
- Safe to Test Adults and Children – The test is recommended for self-collection by individuals aged 14 years and older and with adult-collection by individuals aged 2 years or older.
- Easy to Use – All the components of the nasal swab test are included inside the box with step-by-step Instructions for Use in English and Spanish. No Symptoms Needed – This test is intended to test individuals with or without COVID-19 symptoms. Quick Results – This test is quick and simple. The result is read in 15 minutes
I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.